Emmanuel de Watteville

IMI Intelligent Medical Implants is a medical technology company. The goal of the company is to develop and market an intelligent retinal implant system for degenerative retinal disorders such as Retinitis Pigmentosa or Macular Degeneration and thereby make a contribution to the improvement of the quality of life of blind people. Through the combination of innovative technology from the medical device, IT and micro systems fields, a new class of active medical products has been created allowing, amongst other things, blind people to regain modest visual perception. The company was founded in 2002 and has 30 employees. The company has a process oriented quality management system in accordance with ISO 13485.

PharmARC is a pioneer in the global sourcing of sales and marketing analytics to the global pharmaceutical and healthcare industry. Since its inception in January 2004, PharmARC has worked with over 50 global pharmaceutical companies. PharmARC's key service offerings include Forecasting, Sales Analytics, Market Assessments, Epidemiology Studies, Competitive Intelligence, Key Opinion Leader, Vaccines Consulting, Oncology Consulting, Emerging Markets Consulting, and Technology Services. Strong customer focus on an innovative methodologies, an integrated work model, experience in over 250 therapeutic areas and extensive knowledge of markets in the Americas, EMEA, Asia-Pac, CIS, and BRIC has enabled PharmARC to emerge as a consulting analytics partner of choice. PharmARC has grown to become a 250 strong team of consultants, physicians, and analysts. It was recognized as the second fastest growing small-medium enterprise by the Software Technology Parks of India (STPI) in 2006. Headquartered in Bangalore, India, PharmARC has offices in Basel, Switzerland, Pennington, and New Jersey.

Biocartis SA develops molecular diagnostic solutions. It focuses on Oncology. The firm’s products include Idylla and Oncology assays and mutation tests. It also provides instant access to personalized medicine for patients. The company was founded by Rudi Pauwels in 2007 and is headquartered in Lausanne, Switzerland.

Rheon Medical SA develops adjustable glaucoma drainage devices. The firm manufactures eyeWatch, a drainage device for the treatment of glaucoma. It also offers control unit, an instrument that measures and adjusts the eyeWatch's functional position. The company was founded by Nikolaos Stergiopulos and is headquartered in Lausanne, Switzerland.

BlueBotics SA develops and commercializes the ANT natural feature navigation, which turns any kind of system into an autonomous vehicle. It products include ANT localization, lite, navigation, compare, server and ANT monitor, configuration interface and ANT lab. The firm offers custom, mini and mini lite solutions. The company was founded in 2001 and is headquartered in St-Sulpice, Switzerland.

SEED Biosciences SA offers single-cell solutions to industry players competing in the emerging multi-billion market of personalized medicine. The firm makes DispenCell, a novel pipetting robot to faster isolate single cells for personalized medicine. The company was founded by Georges Muller and is headquartered in Renens, Switzerland.

Cerchia AG is a company based in Zug, CH that was founded in 2020 by Michaël Rey, Thomas Zehnder, and Fabian Bachmann. Cerchia is located in the heart of the Crypto Valley. The Swiss company specializes in connecting real world asset (RWA) thought leaders with institutional investors. The company's services include animation of natural disasters from 1990-2021, such as storms, floods, hail, earthquakes, cold and frost, visualized by James Eagle. Michaël Rey has been the CEO since 2020.